Literature DB >> 10484621

Altered signal pathway in granulocytes from patients with hypercholesterolemia.

G Paragh1, E Kovács, I Seres, T Keresztes, Z Balogh, J Szabó, F Teichmann, G Fóris.   

Abstract

In the present study the signal transduction of the formyl-Met-Leu-Phe receptor was studied in granulocytes obtained from control subjects and patients with elevated low density lipoprotein levels. According to our results, 10 nm formyl-Met-Leu-Phe in control cells activates phospholipase C inducing a pronounced inositol phosphate production followed by a Ca(2+) signal from intracellular pools. The pertussis toxin-sensitive O(2)(-) generation and leukotriene synthesis were moderate. In contrast, in granulocytes from hypercholesterolemic patients, formyl-Met-Leu-Phe triggered an intensive pertussis toxin-insensitive oxidative burst and leukotriene synthesis. The inositol trisphosphate and Ca(2+) signals were decreased significantly in granulocytes of hypercholesterolemic patients and seem to be dependent on the extracellular Ca(2+) content. Furthermore, in the resting granulocytes of hypercholesterolemic patients the [Ca(2+)]i and the membrane-bound protein kinase C activity were higher than in controls, the time of normalization after the low Ca(2+) signal was delayed, while the membrane fluidity was decreased. Our results suggest that in these ex vivo experiments, the high level of circulating low density lipoprotein in patients can affect the membrane composition of granulocytes leading to altered signal transduction by the formyl-Met-Leu-Phe receptor, to altered Ca(2+) pump-activity, and protein kinase C translocation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484621

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils.

Authors:  E Alvarez; V Ruiz-Gutiérrez; F Sobrino; C Santa-María
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

Review 2.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

Review 3.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

4.  Angiotensin II impairs endothelial nitric-oxide synthase bioavailability under free cholesterol-enriched conditions via intracellular free cholesterol-rich membrane microdomains.

Authors:  Eisuke Amiya; Masafumi Watanabe; Norihiko Takeda; Tetsuya Saito; Taro Shiga; Yumiko Hosoya; Tomoko Nakao; Yasushi Imai; Ichiro Manabe; Ryozo Nagai; Issei Komuro; Koji Maemura
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

5.  Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.

Authors:  Aditya J Desai; Maoqing Dong; Blake T Langlais; Amylou C Dueck; Laurence J Miller
Journal:  Am J Clin Nutr       Date:  2017-06-07       Impact factor: 7.045

6.  Impact of ursodeoxycholic acid on a CCK1R cholesterol-binding site may contribute to its positive effects in digestive function.

Authors:  Aditya J Desai; Maoqing Dong; Kaleeckal G Harikumar; Laurence J Miller
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-02       Impact factor: 4.052

Review 7.  Cholecystokinin-induced satiety, a key gut servomechanism that is affected by the membrane microenvironment of this receptor.

Authors:  A J Desai; M Dong; K G Harikumar; L J Miller
Journal:  Int J Obes Suppl       Date:  2016-11-16

8.  Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.

Authors:  Mariann Harangi; Ildikó Seres; Zsuzsa Varga; Gabriella Emri; Zoltán Szilvássy; György Paragh; Eva Remenyik
Journal:  Eur J Clin Pharmacol       Date:  2004-10-14       Impact factor: 2.953

9.  Membrane cholesterol affects stimulus-activity coupling in type 1, but not type 2, CCK receptors: use of cell lines with elevated cholesterol.

Authors:  Kaleeckal G Harikumar; Ross M Potter; Achyut Patil; Valerie Echeveste; Laurence J Miller
Journal:  Lipids       Date:  2013-01-11       Impact factor: 1.880

10.  Effects of acute and chronic low density lipoprotein exposure on neutrophil function.

Authors:  Tatsiana Palvinskaya; Maryellen Antkowiak; Elianne Burg; Christopher C Lenox; Niki Ubags; Angela Cramer; Mercedes Rincón; Anne E Dixon; Michael B Fessler; Matthew E Poynter; Benjamin T Suratt
Journal:  Pulm Pharmacol Ther       Date:  2012-10-17       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.